← Eichor
Study identifier: NCT06727864 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial

Condition: Pulmonary Tuberculosis  ·  Sponsor: Kaohsiung Veterans General Hospital.

PhasePhase 3
Planned participants270
Who can joinAll sexes, 20 Years to 99 Years
Healthy volunteersNo

About this study

Tuberculosis remains an important global health problem, and the world is currently not on track to end the TB epidemic by 2030. With the concerted efforts of the government and medical community, the incidence of TB in Taiwan has gradually decreased, however, Taiwan remains an endemic area for TB. The development of efficacious, safe, and shorter treatment regimens could significantly improve treatment completion rate and reduce transmission of TB. The current treatment guidelines for drug-susceptible TB from the World Health Organization (WHO), American Thoracic Society (ATS), United States Center for Diseases Control (U.S. CDC), Infectious Diseases Society of America (IDSA) and European Respiratory Society (ERS) include 2 months of isoniazid, rifampin, pyrazinamide and ethambutol (HREZ), followed by 4 months of isoniazid, rifampin, and ethambutol(HRE). The current treatment regimen requires 6 months of treatment, despite being highly efficacious, requires long duration of treatment. Adherence to treatment is the major barrier which poses a negative impact to TB control, and increased cost to both the patient and the public health system. Developing an efficacious, safe and short treatment regimen can significantly improve TB management and treatment success rates.

This description comes directly from the study's public registry record.

Talk to the study team

Susan Shin-Jung Lee, M.D., Ph.D.  ·  +886-7342-2121  ·  ssjlee28@yahoo.com.tw

Mei-Ling Lin, University  ·  +886-7342-2121  ·  ed101622@gmail.com

Always discuss trial participation with your own doctor first.

Locations (8)

Far Eastern Memorial HospitalNew Taipei City, Bangiao, TaiwanRecruiting
Taichung HospitalTaichung, West, TaiwanRecruiting
E-DA Healthcare GroupKaoshiung, Yanchao, TaiwanRecruiting
Kaohsiung Medical University Chung-Ho Memorial HospitalKaohsiung City, TaiwanRecruiting
Kaohsiung Veterans General HospitalKaohsiung City, TaiwanRecruiting
Taipei Veterans General HospitalTaipei, TaiwanRecruiting
National Taiwan University HospitalTaipei, TaiwanRecruiting
Linkou Chang Gung Memorial HospitalTaoyuan City, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06727864